Advertisement
Indian
Lot of buzz, interest in market for LIC IPO: Sitharaman
Finance Minister Nirmala Sitharaman ''Now that DRHP (for LIC IPO)...
Skymet predicts ‘normal’ monsoon in 2022
The agency said it is in the process of gathering data sets...
Insurtech player RenewBuy acquires Artivatic.AI for Rs 75cr
The acquisition will allow RenewBuy to extend its tech solutions...
Maintain constant vigil on financial sector, work to achieve inclusive growth: FM to regulators
On the appointment of a new IRDAI chief, Sitharaman said: "I share...
International
Funds and firms call for tougher 2030 EU climate target
In a separate letter, 127 business leaders and 30 investors, some of whom are in the IIGCC, also backed an emissions-cutting target of “at least 55%” by 2030.This would help ensure Europe’s economic recovery from the coronavirus pandemic is driven by green growth, said the companies, which include Unilever, Google, EDF, Deutsche Bank and H&M.
The EU expects a 55% 2030 emissions-cutting goal to require additional energy investments of 350 billion euros ($415 billion) a year from 2021 to 2030, compared with the previous decade.
Vaccine likely in a few months, but life won’t return to normal until end of 2021:Dr. Fauci
“If you’re talking about getting back to a degree of normality which resembles where we were prior to Covid, it’s going to be well into 2021, maybe even towards the end of 2021,” he added.
Nearly 30 U.S. states are reporting downward trends in Covid-19 cases, but the pandemic will likely worsen again, said Fauci, the country’s leading infectious disease expert.
Aviva sells Singapore unit for $1.98 billion as new CEO shifts focus
The British company said on Friday it will sell its majority shareholding in the business to the Singlife consortium, which includes alternative asset firm TPG, Japanese insurer Sumitomo Life and other existing Singlife shareholders.
Promising to shake up the organisation after she took over in July, new CEO Amanda Blanc pledged to reduce its operations in Asia and Europe.
Analysts have said the insurer is operating in too many countries and sectors, and its shares have lagged rivals.
AstraZeneca still aiming for Oxford Covid-19 vaccine by year-end:CEO
The pause highlights the importance of rigorous final-stage trials to pick up on potential side effects or rare events, according to Hatchett. It also shows the need to have a diversified portfolio of Covid-19 vaccines under development, a strategy that CEPI is using with its partners, he said.
“It points to the fact that vaccine development is tricky and unpredictable, and that things that look like they are going along very well can encounter difficulties,” he said.
Briefs
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Events
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Articles
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Features
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Data
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Interviews
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Facts
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.